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Paradoxical Benefits of Psychological Stress in
Inflammatory Dermatoses Models Are Glucocorticoid
Mediated
Tzu-Kai Lin1,2,3,10, Mao-Qiang Man1,10, Juan-Luis Santiago1,4,10, Tiffany C. Scharschmidt1,5, Melanie Hupe1,
Gemma Martin-Ezquerra6, Jong-Kyung Youm1, Yongjiao Zhai1, Carles Trullas7, Kenneth R. Feingold8,9 and
Peter M. Elias1,5
Acute psychological stress (PS) mobilizes metabolic responses that are of immediate benefit to the host, but the
current medical paradigm holds that PS exacerbates systemic and cutaneous inflammatory disorders. Although
the adverse consequences of PS are usually attributed to neuroimmune mechanisms, PS also stimulates an
increase in endogenous glucocorticoids (GCs) that compromises permeability barrier homeostasis, stratum
corneum cohesion, wound healing, and epidermal innate immunity in normal skin. Yet, if such PS-induced
increases in GC were uniformly harmful, natural selection should have eliminated this component of the stress
response. Hence, we hypothesized here instead that stress-induced elevations in endogenous GC could benefit,
rather than aggravate, cutaneous function and reduce inflammation in three immunologically diverse mouse
models of inflammatory diseases. Indeed, superimposed exogenous (motion-restricted) stress reduced, rather
than aggravated inflammation and improved epidermal function in all three models, even normalizing serum IgE
levels in the atopic dermatitis model. Elevations in endogenous GC accounted for these apparent benefits,
because coadministration of mifepristone prevented stress-induced disease amelioration. Thus, exogenous stress
can benefit rather than aggravate cutaneous inflammatory dermatoses through the anti-inflammatory activity of
increased endogenous GC.
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INTRODUCTION
Acute psychological stress (PS) in response to perceived
external threats provokes a suite of metabolic responses that
benefit the host, not only through the rapid mobilization of
endogenous glucocorticoid (GC) but also through autonomic
responses (reviewed in McEwen and Kalia, 2010, Nowotny
et al., 2010). In contrast, it is generally accepted that excessive
PS, an inevitable accompaniment of chronic illness of all types
(Hansel et al., 2010, McEwen and Kalia, 2010), adversely
affects outcomes in chronic inflammatory disorders, as diverse
as inflammatory bowel disease (Reber et al., 2011), coronary
artery disease (Hamer et al., 2010, Ahmadi et al., 2011), and
inflammatory dermatoses, including atopic dermatitis (AD),
psoriasis, and chronic urticaria (Rostenberg, 1960, Gupta
and Gupta, 1996, Tausk and Nousari, 2001). Nevertheless, a
recent body of work supports the concept that moderate
amounts of PS can benefit the host, through a short-term
enhancement of a variety of immune and neuroendocrine
functions (Dhabhar, 2013).
The negative consequences of PS have been extensively
studied in normal skin, where PS in humans (or simply stress
in animals) delays wound healing (Kiecolt-Glaser et al., 1995),
disrupts permeability barrier homeostasis, impairs stratum
corneum (SC) cohesion (Choi et al., 2005a), and compro-
mises epidermal innate immunity (Aberg et al., 2007).
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Although neuroendocrine mechanisms doubtlessly have a role
(Radek and Gallo, 2007), to a large extent, these adverse
cutaneous effects could be attributed to an increase in
endogenous GCs, whose levels increase in proportion to the
extent of stress (Denda et al., 2000, Kao et al., 2003, Choi
et al., 2006). Pertinently, the link to GC could be demon-
strated directly through the ability of either systemically
coadministered antalarmin, an inhibitor of corticotrophin-
releasing factor, or mifepristone (Ru486), a GC receptor anta-
gonist, to normalize function in the face of ongoing stress
(Denda et al., 2000, Choi et al., 2005a, Aberg et al., 2007).
Accordingly, exogenous GC, whether administered systemi-
cally or topically, recapitulated all of these negative outcomes
(Kao et al., 2003, Choi et al., 2006, Aberg et al., 2007). In
theory then, a sustained increase in endogenous GC due to
intrinsic illness–associated or superimposed stress could harm
clinical outcomes in inflammatory disorders by further com-
promising epithelial function. Yet, one could then ask why
this component of the stress response was retained during
evolution, if its consequences are uniformly detrimental.
Alternatively, because of the increase in endogenous GC
that accompanies PS, we hypothesized instead that super-
imposed PS could exert beneficial, rather than deleterious,
effects in inflammatory disorders. Pertinently, supraphysiolo-
gical doses of GC, whether administered systemically or
topically, exert potent anti-inflammatory benefits (Gardner
and Shoback, 2011); conversely, there are multiple, adverse
consequences of GC deficiency in patients with Addison’s
disease (Gardner and Shoback, 2011). To address this issue,
we examined the impact of additional exogenous stress on
inflammation and epidermal function in mouse models of
inflammatory skin disorders. Our results show that intervals of
exogenous stress that universally compromise function in
normal epidermis, paradoxically reduce inflammation and
improve functional parameters in three immunologically
diverse murine dermatosis models. Improvement paralleled
an increase in endogenous GC, whereas blockade of GC
peripheral action prevented the stress-induced improvements
in inflammation and epidermal function, providing the link
between the stress-induced increase in GC and improved
clinical and functional outcomes. Assuming that these results
will also apply to extracutaneous inflammatory disorders,
these findings could explain why this component of the
stress response, previously thought to be deleterious to
health, has been conserved during human evolution.
RESULTS
Stress increases endogenous GC and decreases inflammation in
murine inflammatory dermatosis models
To generate exogenous stress, we deployed restraint (frustration)
for 18 hours (Youm et al., 2013), which results in a significant
increase in endogenous GC levels in comparison with nonre-
strained, control mice (e.g., Denda et al., 1998, Choi et al.,
2006). Stress was administered immediately after each applica-
tion of either an irritant (i.e., the phorbol ester, phorbol 12-
myristate 13-acetate (TPA); irritant contact dermatitis (ICD) model)
or following single versus multiple (3-10) hapten (oxazolone (Ox))
challenges to previously sensitized mice (acute allergic contact
dermatitis (ACD) and chronic allergic contact dermatitis, with
features of AD, respectively). We next assessed whether added
exogenous stress alters the severity of inflammation in these
immunologically diverse, inflammatory dermatoses models.
Irritant contact dermatitis. In these studies, simultaneous expo-
sure to coadministered exogenous stress raised endogenous GC
levels E4-fold (Supplementary Figure 1 online). Although non-
stressed mice demonstrated inflammation 2 hours after a single
topical application of the phorbol ester TPA to the ear, stressed
mice displayed visible reductions in erythema (Figure 1a). Yet, the
ability of exogenous stress to dampen inflammation in the ICD
model declined in mice treated with a higher concentration of
TPA, suggesting a dose–response relationship (Supplementary
Figure 2 online). Moreover, the stress-induced reduction in
inflammation in the ICD mice could be quantified as a significant
decrease in ear thickness in comparison with untreated, non-
stressed controls (Figure 1b). In addition, inflammatory cell
density was reduced (Figure 1e), epidermal mRNA levels of the
proinflammatory cytokines IL-1a and IL-6 declined (Figure 1f;
Po0.1 for IL-6), and a reduction in inflammation was evident in
parallel histologic studies after exposure to exogenous stress
(Supplementary Figure 3A vs. B online). Finally, the stress-
induced increase in endogenous GC accounted for reduced
inflammation, because coadministered Ru486 worsened TPA-
induced inflammation (see below). Together, these results demon-
strate that co-provision of exogenous stress exerts potent anti-
inflammatory activity in a mouse model of ICD.
Acute allergic contact dermatitis model. We next evaluated the
impact of exogenous stress in an ACD mouse model in which
either the hapten, Ox, or vehicle alone was applied once to
opposing ears of previously sensitized mice, under either stressed
or nonstressed conditions. Exogenous stress again markedly
reduced visible erythema and scale in Ox-challenged ears
(Figure 1c), changes that were paralleled by significant reductions
in ear thickness (Figure 1d) and inflammatory cell infiltrations
(Figures 1e and 2g), as well as histologic evidence of a marked
reduction in dermal inflammation (Figure 2a–c and Supplemen-
tary Figure 3C and D online). The stress-induced reductions in
epidermal hyperplasia were mirrored by a normalization of
epidermal hyperplasia and epidermal thickness, further quantified
as a decreased density of proliferating cell nuclear antigen
(PCNA)-positive basal cells (Figure 2d–g). Together, these results
show that the imposition of exogenous stress displays potent anti-
inflammatory activity in a mouse model of ACD.
Atopic dermatitis model. We next assessed the impact of
exogenous stress in a repeatedly hapten-challenged, chronic
contact dermatitis model that exhibits multiple features of human
AD, including the following: (i) elevated serum IgE levels; (ii)
epidermal hyperplasia; (iii) an inflammatory infiltrate enriched in
eosinophils and mast cells; and (iv) a prominent permeability
barrier abnormality (Man et al., 2008). Superimposed stress
markedly reduced epidermal hyperplasia and dermal inflam-
mation in these AD mice (Figure 3a vs. b), and quantitative studies
confirmed the stress-induced decrease in epidermal hyperplasia
(Figure 3d). Finally, concurrent stress significantly reduced serum
IgE levels in the AD model (Supplementary Figure 4 online). Thus,
exogenous stress exerts potent anti-inflammatory activity in a
repeatedly hapten-challenged mouse model, with features of AD.
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Stress improves epidermal function in AD mice
Not only does permeability barrier dysfunction ‘‘drive’’ inflam-
mation, but chronic inflammation in AD further alters epidermal
barrier function in AD (see Elias and Steinhoff, 2008, Elias et al.,
2008, Cork et al., 2009, Irvine et al., 2011). Hence, we next
assessed whether exogenous stress improves epidermal function
in parallel with reduced inflammation in the AD model.
Although both barrier function and SC hydration deteriorated
in AD mice not subjected to exogenous stress, both of these
functions normalized after the imposition of concurrent stress
(Figure 4a and Table 1). Thus, despite the known propensity for
stress to compromise multiple epidermal functions in normal
skin (Denda et al., 2000, Kao et al., 2003, Choi et al., 2005a,
2006, Aberg et al., 2007), simultaneous exposure to exogenous
stress improves two key epidermal functions in an inflammatory
dermatosis model with features of AD.
Stress-induced improvements in inflammation and epidermal
function can be attributed to increased endogenous GC
If exogenous stress reduces inflammation and improves
epidermal function through an increase in endogenous GC,
one would predict that blockade of GC peripheral action
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Figure 1. Stress reduces cutaneous inflammation in irritant and allergic contact dermatitis models. (a, b) To induce irritant contact dermatitis (ICD), both
ears of one group of C57BL/J mice were treated topically with 20ml of 0.03% phorbol 12-myristate 13-acetate (TPA). The ear thickness was measured with
a digital caliper (Mitutoyo, Tokyo, Japan) 18 hours after oxazolone (Ox) or TPA application, and the results are presented in panel d. Frustration (action-restricted)
stress was administered as described in Methods. (c, d) For acute allergic contact dermatitis (ACD), 5% Ox was applied topically once to the flank of C57BL/J mice.
One week later, the ears of one group C57BL/J mice were topically treated with a single dose of 0.5% Ox. After TPA or Ox treatments, parallel groups of
mice were kept individually in 5 11 4 cm box for 18 hours, to induce frustration (restraint model) (Youm et al., 2013). The two-tailed Student’s t-test was used
to determine significant differences.
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should counteract the beneficial effects of stress in AD mice.
Hence, we next coadministered intraperitoneal mifepristone
(Ru486) to ICD and AD mice, with or without superimposed
stress. As predicted, coadministered mifepristone aggravated
epidermal hyperplasia and inflammation in ICD and AD mice,
exposed to exogenous stress (Figure 3c and d, Supplementary
Figure 5A and B online, and Table 1). Finally, barrier function
(but not SC hydration) worsened when mifepristone was
coadministered with exogenous stress (Figure 4b and Table 1).
Together, these results show that exogenous stress improves
inflammation and epidermal barrier function through an
increase in the peripheral action of endogenous GC.
DISCUSSION
Acute PS mobilizes glucose reserves and promotes insulin
resistance as part of a highly conserved, acute response to
perceived external threats that provides net benefits to the host
(Nowotny et al., 2010). In contrast, sustained PS reportedly
provokes and exacerbates both cutaneous and extracutaneous
inflammatory disorders (Hansel et al., 2010, McEwen and
Kalia, 2010). Skin disorders with epidermal functional abnor-
malities, such as psoriasis and AD, seem particularly susceptible
to PS (Rostenberg, 1960, Gupta and Gupta, 1996, Tausk and
Nousari, 2001). According to the current paradigm, the patho-
physiologic basis of PS can be explained by abnormalities in
immune and neuroendocrine mechanisms, which amplify
inflammation and pruritus in these disorders (e.g., O’Sullivan
et al., 1998, Radek and Gallo, 2007). Yet, studies in rodent
models show that the deleterious effects of stress, at least in
normal skin, are largely mediated by increased endogenous
GC levels, based upon studies with the nonspecific GC
receptor antagonist, mifepristone (Ru486), and also sup-
ported by the fact that the administration of exogenous GC
mirrors the stress-induced abnormalities (Denda et al., 2000,
Kao et al., 2003, Choi et al., 2005b, 2006).
An elevation in endogenous GC, explained by altered GC
production and/or peripheral activation, often accompanies
chronic illness. Although such sustained increases in GC are
presumed to pose a further threat to the host (Boonen et al.,
2013, Gomez-Sanchez, 2013), our studies suggest instead that
increases in illness-associated or exogenous stress could be
beneficial. We showed here that a stress-induced increase in
circulating GC ameliorates cutaneous inflammation. As GC
can also be produced within various cell types in the skin, it
remains possible that skin-specific changes in GC could
also have contributed to the apparent benefits of stress.
Accordingly, recent studies have shown that failure to mount
a sufficient cortisol response under stressful conditions can
trigger allergic inflammation and exacerbate disease in AD
patients (Buske-Kirschbaum et al., 2002, 2003, 2007; Yehuda
and Seckl, 2011). Moreover, HPA axis hyporesponsiveness
has been linked to increased severity of the full range of atopic
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Figure 2. Stress reduces epidermal hyperplasia and inflammation in acute allergic contact dermatitis (ACD) mice. (a–c) Representative hematoxylin and
eosin sections of normal or ACD mice, with or without superimposed stress. (d–f) Proliferating cell nuclear antigen (PCNA) immunostaining in parallel sections
(see a–c). (g) Quantification of epidermal hyperplasia (thickness) of nucleated cell layers, PCNAþ cells (PNAþ cells/unit length of basal layer), and
inflammatory cell density/mm2. Bar¼ 20mm.
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inflammatory disorders (Buske-Kirschbaum et al., 2010),
further linked to decreased production of proinflammatory
cytokines, such as IL-1 and tumor necrosis factor-a (Chesnokova
and Melmed, 2002), as well as other neuroendocrine mediators
(Chen and Miller, 2007).
In light of the apparent benefits of exogenous stress in the
dermatosis models, it becomes more difficult to defend
the prevailing hypothesis—i.e., that PS exacerbates chronic
inflammatory disorders. The apparently paradoxical nature of
our results likely can be explained as follows: PS clearly
compromises epidermal function, including innate immune
status, in otherwise normal human (Altemus, et al., 2001,
Garg, et al., 2001) and rodent (Denda, et al., 1998, 2000,
Choi, et al., 2005a, Aberg, et al., 2007) skin. These negative
effects in normal skin appear to be offset by the anti-
inflammatory benefits of exogenous stress demonstrated in
inflamed skin. Indeed, superimposition of exogenous stress
reduced inflammation in the ICD, ACD, and AD models,
conditions whose immunophenotypes differ widely. We show
here further that the benefits of exogenous stress can be
attributed to elevated endogenous GC, as coadministration of
mifepristone, an antagonist of the GCr, reversed the apparent
benefits of stress in the ICD and AD models. Stress, similar to
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Figure 4. Co-administered stress improves epidermal function in the atopic dermatitis (AD) model. (a) Stress improves barrier function and stratum corneum
hydration in AD mice. (b) Coadministration of mifeprostone (Ru486) worsens barrier function, but it does not change hydration in AD mice (note: differences in
basal transepidermal water loss (TEWL) values in a and b reflect two different cohorts of mice).
Table 1. Influence of exogenous stress on cutaneous
function in an AD model
TEWL SC hydration
ADþ nonstressed (n¼ 10) 14.2±1.6* 39.5±3.5
ADþ stressþ vehicle (n¼10) 11.8±1.3* 46.4±4.2
ADþ stressþRu486 (n¼10) 28.4±3.0 34.1±5.1
Significance *Po0.001 vs. Ru486 NS
Abbreviations: AD, atopic dermatitis; NS, nonsignificant; SC, stratum
corneum; TEWL, transepidermal water loss.
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Figure 3. Psychological stress reduces inflammation and epidermal hyperplasia in an atopic dermatitis (AD) model. (a, b) Changes in epidermal hyperplasia
and inflammation in nonstressed versus stressed animals (quantitative data are in d). (c, d) Reversal of benefits of stress following coadministered mifeprostone
(Ru486). One-way analysis of variance with Tukey’s correction was used to determine significant differences. Bar¼ 20mm.
T-K Lin et al.
Glucocorticoid-Mediated Psychological Stress
2894 Journal of Investigative Dermatology (2014), Volume 134
GC, can be anti-inflammatory by a number of related mech-
anisms (Fantuzzi and Ghezzi, 1993, Schleimer, 1993, Campisi
et al., 2002, Baschant and Tuckermann, 2010, Marshall,
2011). For example, it is well accepted that an appropriate
responsiveness of the HPA axis and a subsequent release of
GC may be essential to control overshooting of the immune
response (Elenkov and Chrousos, 2006). Yet, as the anti-
inflammatory benefits of stress also correlated with a parallel
improvement in epidermal function in the AD model, improved
barrier function could contribute to reduced cutaneous
inflammation by several downstream mechanisms—e.g., down-
regulation of the cytokine cascade (Elias and Steinhoff, 2008,
Elias et al., 2008, Elias, 2010). These potent anti-inflammatory
effects, which require hours to days, rather than minutes, of
stress, outweigh the negative impact of elevated GC on
cutaneous homeostasis in otherwise normal skin.
In contrast, PS likely triggers inflammation in a setting of
normal skin that is predisposed to inflammation, such as in
patients predisposed to develop AD or psoriasis (Buske-
Kirschbaum et al., 2001, Wright et al., 2005). Similarly, PS
is thought to trigger extracutaneous inflammatory disorders,
such as allergic asthma (Chen and Miller, 2007), systemic
lupus erythematosus (Pawlak et al., 2003), and inflammatory
bowel disease (Furlan et al., 2006), perhaps also by
compromising epithelial barrier function, cell–cell cohesion,
proliferation, and/or differentiation in these extracutaneous
epithelia. In these epithelia, as in the skin, PS could compro-
mise not only barrier function but also innate immunity, likely
facilitating bacterial colonization, translocation, and invasion
by pathogens, e.g., from the intestinal lumen into the colonic
mucosa (Ibid).
The apparent benefits of PS through the anti-inflammatory
activity of increased endogenous GC production could pro-
vide benefits in combating the sequelae of traumatic injury
and infectious challenges. Thus, conservation of stress reac-
tivity within the HPA axis, with the capability to increase
endogenous GC production, could have equipped humans
with an endogenous anti-inflammatory mechanism in eras
before the availability of exogenous GC as anti-inflammatory
therapy. Yet, although preservation of HPA axis reactivity
likely benefitted humans by dampening inflammation during
illness, a more prolonged increase in PS can decrease HPA
axis reactivity, resulting in a reduction in endogenous GC
levels (Reber et al., 2007). Thus, the potential benefits of PS
through elevated endogenous GC on epithelial barrier func-
tion, inflammation, and innate immunity likely accrue only
during periods of established disease/inflammation, and
predominantly in earlier stages of an inflammatory response.
We propose that a prolonged increase in endogenous GC
production, induced by a variety of different, subacute-to-
chronic stressors (i.e., trauma, surgery, infections, and chronic
inflammation), correlates with the benefits of exogenous GC in
the management of autoimmune and inflammatory diseases,
as well as following life-threatening trauma (e.g., cranioen-
cephalic or spinal cord injury). Together, these studies support
the concept that enhanced GC in response to PS could have
an important role in modulating inflammation and preserving
health in humans.
MATERIALS AND METHODS
Materials
Six- to eight-week-old female hairless mice (hr/hr) and C57BL/J male
mice were purchased from Charles River Laboratories (Wilmington,
MA) and fed a standard mouse diet (Ralston-Purina, St Louis, MO)
and water ad libitum. TPA, 4-ethoxymethylene-2-phenyl-2-oxazolin-
5-one (Ox), and acetone were purchased from Sigma Chemical (St
Louis, MO). Biotinylated anti-PCNA antibody was from CalTag
Laboratories (Burlingame, CA). ABC-peroxidase kit was purchased
from Vector Laboratories (Burlingame, CA).
Experimental protocols and disease models
All animal procedures were approved by the Animal Studies
Subcommittee of the San Francisco Veterans Affairs Medical Center
and performed in accordance with their guidelines. As a model of
ICD, the ears of C57BL/J mice were treated tropically with either
20ml of TPA (0.03%) or ethanol vehicle alone to the opposite ear.
Two hours after applications, we assessed changes in ear thickness
and histologic evidence of inflammation as we have described (Sheu
et al., 1998, Fowler et al., 2003). As a model of ACD, mice were
sensitized with a single application of the hapten, 3% Ox, and
housed in regular cages thereafter. One week later, mouse ears were
challenged with 20ml of 0.5% Ox. After either TPA treatments or a
second Ox challenge (0.5%), separate cohorts of mice were
kept individually in a 5 11 4 cm box for 18 hours, a model
that induces sustained stress. Changes in ear thickness were
measured with a digital caliper (Mitutoyo, Tokyo, Japan) 18 hours
after TPA or Ox applications. For the chronic contact dermatitis with
features of AD model, three groups of hairless mice were sensitized
by topical application of 10ml of 3% Ox, as above. One week later,
both groups of Ox-treated mice were treated topically with 60ml of
0.05% Ox in ethanol once daily for 4 days. Immediately after each
Ox application, one group of mice was kept in regular cages and
another two groups of mice were stressed by individual housing in
5 11 4 cm boxes for 18 hours daily for 4 days. An additional
cohort of similarly treated stressed mice was given a single
intraperitoneal dose of mifepristone (Ru486; 170mg) in corn oil.
Stressed mice injected with corn oil alone served as controls. At the
end of the treatment period, transepidermal water loss, SC hydration,
and skin surface pH were assessed with respective probes connected
to a Tewameter (MPA5, Courage & Khazaka, Cologne, Germany), as
described previously (Man et al., 2008, Hatano et al., 2011). Skin
samples for PCNA, hematoxylin and eosin staining, and electron
microscopy were taken immediately after functional determinations.
Serum IgE and GC measurements
Blood samples were collected from AD mice, with or without
superimposed stress. Serum IgE concentrations were determined
with a mouse IgE ELISA quantification kit from Bethyl Laborato-
ries (Montgomery, TX), by following instructions provided by the
manufacturer.
Immunohistochemistry
For the determination of epidermal proliferation, a previously des-
cribed method was used (Man, et al., 2008). Briefly, 5-mm paraffin
sections were incubated with an antibody against proliferating
cell nuclear antigen (Ki67) (CalTag Laboratories) overnight at 4 1C.
Immunostaining was detected by the ABC peroxidase method.
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Sections were visualized with a Zeiss Microscope (Jena, Germany),
and digital images were taken with Axio Vision software 3.1 (Carl
Zeiss Vision, Munich, Germany).
Quantitative PCR for mRNA expression
Total epidermal RNA was isolated from haired mouse treated for 9
days as described above using TRIzol Reagent (Invitrogen Ambion
RNA catalog number 15596026) according to the manufacturer’s
description. First-strand cDNA was synthesized from 1mg of total RNA
with the Transcriptor First-Strand cDNA Synthesis Kit (Roche, India-
napolis, IN; catalog number 04897030001) in a total volumn of 20ml.
The real-time PCR contained 60 ng of reversed-transcribed cDNA,
300 nM each of forward and reverse primers, and 10ml of 2
SensiMix SYBr Hi-ROX Master mix (Bioline, Stockholm, Sweden;
catalog number QT605-05) in a final volume of 20ml in 384-well
plates using the ABI 7900 HT Real-time PCR System. Quantification
was performed by the comparative threshold cycle method with
mouse glyceraldehyde-3-phosphate dehydrogenase used for normal-
ization. The primer sequences for tumor necrosis factor-a
were 50-GCCTCTTCTCATTCCTGCTTG-30 (forward) and 50-CTGATG
AGAGGGAGGCCATT-30 (reverse). The primer sequences for IL-6
were 50-GAGGATACCACTCCCAACAGACC-30 (forward) and 50-AAG
TGCATCATCGTTGTTCATACA-30 (reverse). The primer sequences for
mouse glyceraldehyde-3-phosphate dehydrogenase were 50-AAGGT
CATCCCAGAGCTGAA-30 (forward) and 50-ATGTAGGCCATGAGGT
CCAC-30 (reverse). Relative expression of the mRNAs compared with
mRNA in normal control mice was calculated. Data are expressed as
percentage of control (setting normal control as 100%).
Inflammatory cell quantifications
The number of inflammatory cells infiltrating the ear was counted on
printed photographs at every 5-cm segment of ear sections stained
with hematoxylin and eosin and captured at  20. The data are
presented as the mean of all areas counted per cm2 (mean±SEM).
Quantification of epidermal thickness, proliferation, and
inflammatory cell density
Thickness of the epidermal nucleated cell layers was measured on  100
micrographs taken every 2cm along the epidermis from biopsies from
normal untreated and repeated Ox-treated mice, with or without
additional stress (n¼ 10 sites from each group). The data presented
depict the mean of all measured points ±SEM. The number of PCNA-
positive cells was counted on  100 micrographs at 1-cm frequencies
along the epidermis and presented as the mean of all PCNA-positive
cells/cm ±SEM. The density of inflammatory cells in the dermis was
counted at 4-cm frequencies along the overlying epidermis, in an area
between the basement membrane and 4cm below the basement
membrane, and presented as the mean of inflammatory cells/cm2±SEM.
Statistics
GraphPad Prism 4 software was used for all statistical analyses. A
two-tailed Student’s t-test was used to determine significant differ-
ences for comparisons between two groups. A one-way analysis of
variance, with Tukey’s correction, was used to determine significant
differences, when three or more groups were compared.
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